Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 19:57
Amgen 1 Year Total Returns (Daily) : 53.88% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 53.88% |
| August 20, 2026 | 50.70% |
| August 19, 2026 | 54.17% |
| August 18, 2026 | 49.70% |
| August 17, 2026 | 45.71% |
| August 14, 2026 | 47.33% |
| August 13, 2026 | 48.75% |
| August 12, 2026 | 50.42% |
| August 11, 2026 | 49.69% |
| August 10, 2026 | 49.09% |
| August 07, 2026 | 48.68% |
| August 06, 2026 | 46.49% |
| August 05, 2026 | 39.99% |
| August 04, 2026 | 33.05% |
| August 03, 2026 | 31.45% |
| July 31, 2026 | 34.44% |
| July 30, 2026 | 32.49% |
| July 29, 2026 | 31.53% |
| July 28, 2026 | 34.39% |
| July 27, 2026 | 26.41% |
| July 24, 2026 | 25.53% |
| July 23, 2026 | 23.75% |
| July 22, 2026 | 23.34% |
| July 21, 2026 | 27.50% |
| July 20, 2026 | 27.26% |
| Date | Value |
|---|---|
| July 17, 2026 | 26.50% |
| July 16, 2026 | 28.00% |
| July 15, 2026 | 26.18% |
| July 14, 2026 | 23.19% |
| July 13, 2026 | 25.74% |
| July 10, 2026 | 24.61% |
| July 09, 2026 | 26.31% |
| July 08, 2026 | 27.62% |
| July 07, 2026 | 29.43% |
| July 06, 2026 | 26.56% |
| July 02, 2026 | 29.83% |
| July 01, 2026 | 28.11% |
| June 30, 2026 | 33.59% |
| June 29, 2026 | 34.01% |
| June 26, 2026 | 32.24% |
| June 25, 2026 | 29.63% |
| June 24, 2026 | 30.45% |
| June 23, 2026 | 31.20% |
| June 22, 2026 | 22.72% |
| June 18, 2026 | 20.06% |
| June 17, 2026 | 21.33% |
| June 16, 2026 | 21.22% |
| June 15, 2026 | 22.30% |
| June 12, 2026 | 23.07% |
| June 11, 2026 | 24.98% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 29.10% |
| Regeneron Pharmaceuticals, Inc. | 40.13% |
| AbbVie, Inc. | 30.40% |
| Biogen, Inc. | 55.82% |
| Vertex Pharmaceuticals, Inc. | 37.89% |